Literature DB >> 18816181

Dramatic response to cholestyramine in a patient with Graves' disease resistant to conventional therapy.

Arántzazu Sebastián-Ochoa1, Miguel Quesada-Charneco, Diego Fernández-García, Rebeca Reyes-García, Pedro Rozas-Moreno, Fernando Escobar-Jiménez.   

Abstract

BACKGROUND: Resistance to the conventional treatment of hyperthyroidism with antithyroid drugs is not commonly found in clinical practice, and only few other treatment options have been reported on in detail. For example, surgery or radioiodine ablation are well-accepted interventions that must be always considered. The euthyroid state is strongly recommended before both of these as this might reduce complications. There are few studies indicating that bile acid sequestrants, when added to antithyroid drugs, produce a more rapid decline in serum thyroid hormone levels and that this effect is maintained for at least 4 weeks. Complete normalization of serum thyroid hormone levels is generally not expected, however.
SUMMARY: We report a patient whose thyrotoxicosis failed to respond to conventional treatment. The patient remained persistently hyperthyroid, both clinically and biochemically, despite several months of methimazole and propranolol and the addition of iodine. Cholestyramine, a bile acid sequestrant, was then added, and a dramatic improvement was observed.
CONCLUSION: We report a patient who was resistant to conventional antithyroid drugs in whom thyroid hormone levels completely normalized after 1 week of additional treatment with cholestyramine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18816181     DOI: 10.1089/thy.2008.0094

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

Review 1.  Preoperative management in patients with Graves' disease.

Authors:  Eliana Piantanida
Journal:  Gland Surg       Date:  2017-10

2.  Resistant type 2 amiodarone-induced thyrotoxicosis responsive to cholestyramine as an adjunctive therapy.

Authors:  Aisha Rummaan; Maryam Maryam; Awais Ali; Snigdhendu Mandal; Tamar Saeed
Journal:  Clin Med (Lond)       Date:  2021-09       Impact factor: 5.410

3.  Resistant thyrotoxicosis in a patient with graves disease: a case report.

Authors:  Taimur Saleem; Aisha Sheikh; Qamar Masood
Journal:  J Thyroid Res       Date:  2011-08-10

Review 4.  Role of Cholestyramine in Refractory Hyperthyroidism: A Case Report and Literature Review.

Authors:  Khaled A Alswat
Journal:  Am J Case Rep       Date:  2015-07-24

5.  Refractory Graves' Disease Successfully Cured by Adjunctive Cholestyramine and Subsequent Total Thyroidectomy.

Authors:  Yeoree Yang; Seawon Hwang; Minji Kim; Yejee Lim; Min Hee Kim; Sohee Lee; Dong Jun Lim; Moo Il Kang; Bong Yun Cha
Journal:  Endocrinol Metab (Seoul)       Date:  2015-09-22

6.  Thyroid Storm Presenting as Psychosis.

Authors:  Dimpi Desai; Sara Zahedpour Anaraki; Neetha Reddy; Eric Epstein; Vafa Tabatabaie
Journal:  J Investig Med High Impact Case Rep       Date:  2018-05-18

7.  Resistant Thyrotoxicosis due to Graves' Disease in Pregnancy: Case Report and Review of the Literature.

Authors:  Anastasia Linardi; Ekaterini Michou; Ioannis Ilias; Foteini Petychaki; Ioannis Kakoulidis; Athina Pappa; Eftychia Koukkou
Journal:  Cureus       Date:  2018-08-30

Review 8.  Very rare case of Graves' disease with resistance to methimazole: a case report and literature review.

Authors:  Yusaku Mori; Munenori Hiromura; Michishige Terasaki; Hideki Kushima; Makoto Ohara; Tomoyasu Fukui; Yasuyoshi Takahashi; Sho-Ichi Yamagishi
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

9.  Cholestyramine Use for Rapid Reversion to Euthyroid States in Patients with Thyrotoxicosis.

Authors:  Jeonghoon Ha; Kwanhoon Jo; Borami Kang; Min Hee Kim; Dong Jun Lim
Journal:  Endocrinol Metab (Seoul)       Date:  2016-07-26

10.  Use of Adjunctive Therapy to Achieve Preoperative Euthyroidism in Graves' Disease: A Case Report.

Authors:  Noor Abdulghani Alghanim; Shymaa M Alkahtani; Fatimah S Assari; Sarah W Alnosaier; Reham M Bader; Isra E Elmahi; Mariam M Hendaz; Amal Alhefdhi
Journal:  Am J Case Rep       Date:  2020-08-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.